TLDR Accenture (ACN) stock dropped 4% and hit a 52-week low of around $182, pressured by a FY2026 revenue guidance miss ($71.8B–$73.2B vs. consensus ~$73.9B). DespiteTLDR Accenture (ACN) stock dropped 4% and hit a 52-week low of around $182, pressured by a FY2026 revenue guidance miss ($71.8B–$73.2B vs. consensus ~$73.9B). Despite

Accenture (ACN) Stock Falls 4% — But UBS Says the Market Is Missing the Bigger Picture

2026/04/10 23:23
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Accenture (ACN) stock dropped 4% and hit a 52-week low of around $182, pressured by a FY2026 revenue guidance miss ($71.8B–$73.2B vs. consensus ~$73.9B).
  • Despite the weak guidance, Accenture beat Q2 earnings with EPS of $2.93 vs. the $2.84 consensus, and revenue of $18.04B, up 7.8% year over year.
  • UBS analyst Kevin McVeigh argues the market is undervaluing Accenture’s AI strategy, pointing to 200% compound annual growth in AI-related revenue since fiscal 2023.
  • Accenture raised its FY2026 acquisition target to $5B (from $3B), with $1.6B already deployed, including purchases of Keepler Data Tech, NeuraFlash, Halfspace, and Decho.
  • Microsoft (MSFT), also highlighted in the AI conversation, is down 21% year to date but trades at its cheapest valuation in roughly a decade, near 22x trailing earnings.

Accenture (ACN) opened Friday at $186.04 after dropping 4%. The stock has now hit a fresh 52-week low, with its 12-month range running from $182.38 to $325.71. The drop reflects investor concern following a guidance update that came in below what Wall Street was expecting.


ACN Stock Card
Accenture plc, ACN

Management guided FY2026 revenue of $71.8 billion to $73.2 billion. Analysts had been looking for closer to $73.9 billion. That gap was enough to push the stock to its lowest level in a year, even as the underlying quarterly numbers looked solid.

Accenture’s most recently reported quarter showed EPS of $2.93, beating the consensus of $2.84 by $0.09. Revenue came in at $18.04 billion, up 7.8% from the same period last year, and above the $17.80 billion estimate. Return on equity was 26.33%.

The company also announced a quarterly dividend of $1.63 per share, payable May 15 to holders of record as of April 9. That works out to a 3.5% annualized yield on current prices.

UBS Sees Undervalued AI Upside

UBS analyst Kevin McVeigh published a research note flagging what he sees as a market mispricing. His focus was Accenture’s latest acquisition, Spain-based Keepler Data Tech, which adds roughly 240 specialists in data science, machine learning, and cloud architecture.

McVeigh’s broader argument is that Accenture’s AI strategy is more coordinated and faster-growing than the market is currently pricing in. Since launching generative AI initiatives in fiscal 2023, Accenture has grown AI-related revenue to about $2.7 billion by fiscal 2025 — a compound annual growth rate of roughly 200%. That outpaces even its early cloud business, which grew at around 132% in its first years.

Accenture raised its fiscal 2026 acquisition target from $3 billion to $5 billion. The company has already deployed about $1.6 billion across deals including NeuraFlash, Halfspace, and Decho. McVeigh views this as a shift toward higher-margin, technology-driven business rather than traditional labor-intensive consulting.

The company now has more than 85,000 AI professionals on staff. Bookings tied to AI and data partnerships are expected to more than double in fiscal 2026.

Institutional Activity Remains Active

Institutional investors continued to move around positions in ACN during recent quarters. Capital International Investors grew its stake by 41.1% in Q3, bringing its total to over 17 million shares valued at roughly $4.2 billion. Massachusetts Financial Services added 12.8% to its position, now holding about 10.1 million shares.

DDD Partners LLC opened a new position in Q4, acquiring 9,090 shares valued at approximately $2.44 million.

Institutional and hedge fund ownership currently stands at 75.14% of total shares.

Analyst consensus remains cautious but generally positive. Eighteen analysts have a Buy rating on the stock. Ten have a Hold. The average price target is $274.88, well above where the stock is trading today.

The stock’s 50-day moving average stands at $210.98 and its 200-day average at $241.88. At Friday’s open, ACN was trading below both.

The post Accenture (ACN) Stock Falls 4% — But UBS Says the Market Is Missing the Bigger Picture appeared first on CoinCentral.

Market Opportunity
4 Logo
4 Price(4)
$0.017926
$0.017926$0.017926
+3.93%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!